TREM2 and Alzheimer disease: TREM2 binds various ligands, including lipids, lipoproteins, and the amyloid β (Aβ) peptide, a key pathogenic peptide early in AD pathogenesis (Deczkowska et al, 2018a; Lewcock et al, 2020; Hou et al, 2022).